{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:56:04Z","timestamp":1792853764261,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T00:00:00Z","timestamp":1528761600000},"content-version":"vor","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Intramural Research Program of the NIH"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Disease","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cancercell.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ccell.2017.04.012","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T14:02:51Z","timestamp":1495720971000},"page":"833-843.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":468,"title":["Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma"],"prefix":"10.1016","volume":"31","author":[{"given":"Michail S.","family":"Lionakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieron","family":"Dunleavy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Roschewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte C.","family":"Widemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Butman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yandan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane E.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Melani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine S.","family":"Higham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigar V.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Ceribelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Gea-Banacloche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sucharita","family":"Bhaumik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryalice","family":"Stetler-Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Heiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth M.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M.","family":"Staudt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wyndham H.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2017.04.012_bib1","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1200\/JCO.2005.13.524","article-title":"Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma","volume":"23","author":"Abrey","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2017.04.012_bib2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2217\/cns.15.34","article-title":"Late relapses in primary CNS lymphoma after complete remissions with high-dose methotrexate monotherapy","volume":"4","author":"Ambady","year":"2015","journal-title":"CNS Oncol."},{"key":"10.1016\/j.ccell.2017.04.012_bib3","doi-asserted-by":"crossref","first-page":"e61359","DOI":"10.1371\/journal.pone.0061359","article-title":"Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer","volume":"8","author":"Anders","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2017.04.012_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1172\/JCI11991","article-title":"Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB","volume":"107","author":"Baldwin","year":"2001","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccell.2017.04.012_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly","volume":"26","author":"Bliss","year":"1939","journal-title":"Ann. Appl. Biol."},{"key":"10.1016\/j.ccell.2017.04.012_bib6","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1158\/1078-0432.CCR-14-2116","article-title":"Genome-wide analysis uncovers novel recurrent alterations in primary central nervous system lymphomas","volume":"21","author":"Braggio","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2017.04.012_bib7","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.18632\/oncotarget.2080","article-title":"Mutational analysis of primary central nervous system lymphoma","volume":"5","author":"Bruno","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ccell.2017.04.012_bib8","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.4049\/jimmunol.1300057","article-title":"Bruton's tyrosine kinase is required for apoptotic cell uptake via regulating the phosphorylation and localization of calreticulin","volume":"190","author":"Byrne","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2017.04.012_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00280-005-0001-z","article-title":"Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours","volume":"57","author":"Caraglia","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ccell.2017.04.012_bib10","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood-2015-10-673236","article-title":"Targetable genetic features of primary testicular and primary central nervous system lymphomas","volume":"127","author":"Chapuy","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2017.04.012_bib11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.clim.2007.05.004","article-title":"Role of Toll-like receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromised hosts","volume":"124","author":"Chignard","year":"2007","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ccell.2017.04.012_bib12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/CMR.00055-08","article-title":"Pathogenesis of Aspergillus fumigatus in invasive aspergillosis","volume":"22","author":"Dagenais","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ccell.2017.04.012_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2017.04.012_bib14","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.4155\/bio.15.159","article-title":"Bioanalysis of ibrutinib and its active metabolite in human plasma: selectivity issue, impact assessment and resolution","volume":"7","author":"de Vries","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ccell.2017.04.012_bib15","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.4049\/jimmunol.177.6.3994","article-title":"Aspergillus fumigatus induces innate immune responses in alveolar macrophages through the MAPK pathway independently of TLR2 and TLR4","volume":"177","author":"Dubourdeau","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2017.04.012_bib16","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1182\/blood-2013-06-507947","article-title":"Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes","volume":"122","author":"Dubovsky","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2017.04.012_bib17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1200\/JCO.2003.09.139","article-title":"Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience","volume":"21","author":"Ferreri","year":"2003","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2017.04.012_bib18","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/blood-2010-04-281170","article-title":"Neutrophil development and function critically depend on Bruton tyrosine kinase in a mouse model of X-linked agammaglobulinemia","volume":"117","author":"Fiedler","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2017.04.012_bib19","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1056\/NEJMra064928","article-title":"Infection in solid-organ transplant recipients","volume":"357","author":"Fishman","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2017.04.012_bib20","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1073\/pnas.1311846111","article-title":"High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells","volume":"111","author":"Mathews Griner","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2017.04.012_bib21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/bjh.14080","article-title":"MYD88 (L265P) mutation is associated with an unfavourable outcome of primary central nervous system lymphoma","volume":"177","author":"Hattori","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ccell.2017.04.012_bib22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.15252\/emmm.201404556","article-title":"Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus","volume":"7","author":"Herbst","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ccell.2017.04.012_bib23","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.4049\/jimmunol.176.6.3635","article-title":"Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production","volume":"176","author":"Horwood","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2017.04.012_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/1074-7613(95)90114-0","article-title":"Defective B cell development and function in Btk-deficient mice","volume":"3","author":"Khan","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2017.04.012_bib25","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.4049\/jimmunol.1002760","article-title":"TLR9 is actively recruited to Aspergillus fumigatus phagosomes and requires the N-terminal proteolytic cleavage domain for proper intracellular trafficking","volume":"185","author":"Kasperkovitz","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2017.04.012_bib26","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1054\/bjoc.2000.1459","article-title":"High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours","volume":"83","author":"Koukourakis","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccell.2017.04.012_bib27","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1038\/bcj.2013.28","article-title":"High prevalence of oncogenic MYD88 and CD79B mutations in diffuse\u00a0large B-cell lymphomas presenting at immune-privileged sites","volume":"3","author":"Kraan","year":"2013","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ccell.2017.04.012_bib28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/leu.2013.348","article-title":"High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma","volume":"28","author":"Kraan","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2017.04.012_bib29","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/neuonc\/now033","article-title":"Primary CNS lymphoma at first relapse\/progression: characteristics, management, and outcome of 256 patients from the French LOC network","volume":"18","author":"Langner-Lemercier","year":"2016","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ccell.2017.04.012_bib30","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/myc.12081","article-title":"Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study","volume":"56","author":"Lewis","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.ccell.2017.04.012_bib31","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1172\/JCI119384","article-title":"The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung","volume":"99","author":"Limper","year":"1997","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccell.2017.04.012_bib32","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1200\/JCO.2004.01.175","article-title":"CNS metastases in breast cancer","volume":"22","author":"Lin","year":"2004","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2017.04.012_bib33","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ccell.2017.04.012_bib34","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1124\/dmd.105.008201","article-title":"Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration","volume":"34","author":"Liu","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ccell.2017.04.012_bib35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/nan.12259","article-title":"Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas","volume":"42","author":"Nakamura","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.ccell.2017.04.012_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2017.04.012_bib37","doi-asserted-by":"crossref","first-page":"e85834","DOI":"10.1371\/journal.pone.0085834","article-title":"Btk regulates macrophage polarization in response to lipopolysaccharide","volume":"9","author":"Ni Gabhann","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2017.04.012_bib38","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood-2007-07-102343","article-title":"Bmx tyrosine kinase regulates TLR4-induced IL-6 production in human macrophages independently of p38 MAPK and NFkappaB activity","volume":"111","author":"Palmer","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2017.04.012_bib39","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/jid.2012.102","article-title":"MYD88 somatic mutation is a genetic feature of primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"132","author":"Pham-Ledard","year":"2012","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ccell.2017.04.012_bib40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/clim.2002.5241","article-title":"Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study","volume":"104","author":"Plebani","year":"2002","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ccell.2017.04.012_bib41","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1128\/IAI.00998-08","article-title":"Toll-like receptor 9 modulates immune responses to Aspergillus fumigatus conidia in immunodeficient and allergic mice","volume":"77","author":"Ramaprakash","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ccell.2017.04.012_bib42","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1128\/IAI.00047-08","article-title":"Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA","volume":"76","author":"Ramirez-Ortiz","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ccell.2017.04.012_bib43","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1080\/15287390306417","article-title":"Efficacy of a technique for exposing the mouse lung to particles aspirated from the pharynx","volume":"66","author":"Rao","year":"2003","journal-title":"J.\u00a0Toxicol. Environ. Health A"},{"key":"10.1016\/j.ccell.2017.04.012_bib44","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1182\/blood-2013-06-453084","article-title":"How I treat CNS lymphomas","volume":"122","author":"Rubenstein","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2017.04.012_bib45","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1200\/JCO.2012.46.9957","article-title":"Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202)","volume":"31","author":"Rubenstein","year":"2013","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2017.04.012_bib46","first-page":"1593","article-title":"Ibrutinib for chronic lymphocytic leukemia","volume":"374","author":"Ruchlemer","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2017.04.012_bib47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1124\/dmd.114.060061","article-title":"Absorption, metabolism, and excretion of oral (1)(4)C radiolabeled ibrutinib: an open-label, phase I, single-dose study in healthy men","volume":"43","author":"Scheers","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ccell.2017.04.012_bib48","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3171\/jns.1995.83.6.1029","article-title":"Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy","volume":"83","author":"Siegal","year":"1995","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.ccell.2017.04.012_bib49","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.qco.0000172698.52408.be","article-title":"Infectious complications in organ transplant recipients with the use of calcineurin-inhibitor agent-based immunosuppressive regimens","volume":"18","author":"Singh","year":"2005","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ccell.2017.04.012_bib50","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2016.152017","article-title":"The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1 mediated neutrophil activation","author":"Stadler","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.ccell.2017.04.012_bib51","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/PAS.0000000000000592","article-title":"Frequent MYD88 L265P and CD79B mutations in primary breast diffuse large B-cell lymphoma","volume":"40","author":"Taniguchi","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ccell.2017.04.012_bib52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/j.seminoncol.2004.08.002","article-title":"Pegylated liposomal doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studies","volume":"31","author":"Vail","year":"2004","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ccell.2017.04.012_bib53","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/leu.2014.264","article-title":"The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing","volume":"29","author":"Vater","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2017.04.012_bib54","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/mi.2014.65","article-title":"Classical versus alternative macrophage activation: the Ying and the Yang in host defense against pulmonary fungal infections","volume":"7","author":"Leopold Wager","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ccell.2017.04.012_bib55","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1182\/asheducation-2013.1.584","article-title":"Treatment strategies for aggressive lymphomas: what works?","volume":"2013","author":"Wilson","year":"2013","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.ccell.2017.04.012_bib56","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nm.3884","article-title":"Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma","volume":"21","author":"Wilson","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2017.04.012_bib57","doi-asserted-by":"crossref","first-page":"13447","DOI":"10.1073\/pnas.1514944112","article-title":"Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens","volume":"112","author":"Young","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610817301678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610817301678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:09:30Z","timestamp":1569370170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610817301678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1535610817301678"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2017.04.012","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727663539.793535341","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.727663539.793562617","asserted-by":"object"}]},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2017.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2017.05.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}